These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women. Yi J; Jin H; Zhang R; Zhang S; Chen P; Yu X; Zhang X J Endocrinol Invest; 2018 Jun; 41(6):663-670. PubMed ID: 29151239 [TBL] [Abstract][Full Text] [Related]
4. Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. Liu Y; Prentice KJ; Eversley JA; Hu C; Batchuluun B; Leavey K; Hansen JB; Wei DW; Cox B; Dai FF; Jia W; Wheeler MB Cell Rep; 2016 Mar; 14(12):2889-900. PubMed ID: 26997281 [TBL] [Abstract][Full Text] [Related]
5. CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome. Lankinen MA; Hanhineva K; Kolehmainen M; Lehtonen M; Auriola S; Mykkänen H; Poutanen K; Schwab U; Uusitupa M PLoS One; 2015; 10(4):e0124379. PubMed ID: 25874636 [TBL] [Abstract][Full Text] [Related]
6. Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population. Zhang S; Chen P; Jin H; Yi J; Xie X; Yang M; Gao T; Yang L; Hu C; Zhang X; Yu X Sci Rep; 2017 Jun; 7(1):3114. PubMed ID: 28596534 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of Circulating Determinants of Beta-Cell Function in Women With and Without Gestational Diabetes. Retnakaran R; Ye C; Kramer CK; Connelly PW; Hanley AJ; Sermer M; Zinman B J Clin Endocrinol Metab; 2016 Jul; 101(7):2683-91. PubMed ID: 27023450 [TBL] [Abstract][Full Text] [Related]
8. 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) prevents high fat diet-induced insulin resistance via maintenance of hepatic lipid homeostasis. Mohan H; Brandt SL; Kim JH; Wong F; Lai M; Prentice KJ; Al Rijjal D; Magomedova L; Batchuluun B; Burdett E; Bhattacharjee A; Cummins CL; Belsham DD; Cox B; Liu Y; Wheeler MB Diabetes Obes Metab; 2019 Jan; 21(1):61-72. PubMed ID: 30062833 [TBL] [Abstract][Full Text] [Related]
9. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals. Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682 [TBL] [Abstract][Full Text] [Related]
10. A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate induces cell damage to proximal tubular cells via the generation of a radical intermediate. Miyamoto Y; Iwao Y; Mera K; Watanabe H; Kadowaki D; Ishima Y; Chuang VT; Sato K; Otagiri M; Maruyama T Biochem Pharmacol; 2012 Nov; 84(9):1207-14. PubMed ID: 22898098 [TBL] [Abstract][Full Text] [Related]
11. Metabolomics approaches shine new light on diabetes mechanisms. Koutsouki E Future Med Chem; 2014 May; 6(8):853. PubMed ID: 24962277 [No Abstract] [Full Text] [Related]
12. CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression? Koppe L; Poitout V Trends Endocrinol Metab; 2016 Jul; 27(7):439-440. PubMed ID: 27132217 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous quantification of coproporphyrin-I and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid in human plasma using ultra-high performance liquid chromatography coupled to tandem mass spectrometry. Suzuki Y; Sasamoto Y; Yoshijima C; Tanaka R; Ono H; Ando T; Shin T; Mimata H; Itoh H; Ohno K J Pharm Biomed Anal; 2020 May; 184():113202. PubMed ID: 32114159 [TBL] [Abstract][Full Text] [Related]
14. Furan fatty acids - Beneficial or harmful to health? Xu L; Sinclair AJ; Faiza M; Li D; Han X; Yin H; Wang Y Prog Lipid Res; 2017 Oct; 68():119-137. PubMed ID: 29051014 [TBL] [Abstract][Full Text] [Related]
15. Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients? Luce M; Bouchara A; Pastural M; Granjon S; Szelag JC; Laville M; Arkouche W; Fouque D; Soulage CO; Koppe L Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29783628 [TBL] [Abstract][Full Text] [Related]
16. Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial. Zheng JS; Lin M; Imamura F; Cai W; Wang L; Feng JP; Ruan Y; Tang J; Wang F; Yang H; Li D Sci Rep; 2016 Jul; 6():29522. PubMed ID: 27404516 [TBL] [Abstract][Full Text] [Related]